Compare BIO & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | XPEV |
|---|---|---|
| Founded | 1952 | 2015 |
| Country | United States | China |
| Employees | 7450 | 19884 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Auto Manufacturing |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 14.4B |
| IPO Year | N/A | N/A |
| Metric | BIO | XPEV |
|---|---|---|
| Price | $312.45 | $16.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $339.75 | $23.08 |
| AVG Volume (30 Days) | 471.8K | ★ 5.8M |
| Earning Date | 04-30-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | $25.76 |
| Revenue Next Year | $3.20 | $25.98 |
| P/E Ratio | $9.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $14.72 |
| 52 Week High | $343.12 | $28.20 |
| Indicator | BIO | XPEV |
|---|---|---|
| Relative Strength Index (RSI) | 68.29 | 53.50 |
| Support Level | $293.88 | $16.43 |
| Resistance Level | $330.54 | $16.88 |
| Average True Range (ATR) | 9.86 | 0.55 |
| MACD | 6.66 | 0.17 |
| Stochastic Oscillator | 90.63 | 75.73 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold about 430,000 EVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.